InvestorsHub Logo
Followers 1
Posts 77
Boards Moderated 0
Alias Born 04/26/2012

Re: FortStCowboy post# 6529

Wednesday, 09/17/2014 2:51:44 PM

Wednesday, September 17, 2014 2:51:44 PM

Post# of 9929
What year?

Bojangles and Shirley - Stair Step Tapdance Movie, 1935
The Moody Blues - Ride my see saw, 1968

"Breakthrough" - An award winning movie that will air at a theater near you, 2015?

---------------------------------------------------

The following is a bit long I know, but was written by myself around Memorial Day. Today I changed only a few sentences as an update. Bathroom reading maybe.

I think it would read better if I could attach it in Word Doc with the photos--but I don't know how or cannot.
pnw1


----------------------------------------------------

"Breakthrough"

An award winning movie that will soon be ready for Hollywood to make


Movie Overview – Based on A True Story:

A tiny company, with an "unprecedented" cancer breakthrough (Provectus Biopharmaceuticals, PVCT) has been able to put off giving in to what can be, overly controlling money of big pharmacy, while two world class inventors of Oakridge Labs, TN discover a novel drug for melanoma, liver, breast, pancreatic, bladder, lung and potentially other cancers.
The company is informed by the US Food and Drug Administration (FDA) that the next step is to apply for "Breakthrough Therapy Designation" (BTD) but receives a BTD denial letter from FDA on May 21, 2014 via email, one day before the company is scheduled to ring the opening bell of the NYSE, May 22, 2014.
The company passes all investigations of the NYSE after challenges of Over the Counter (OTC) stock exchange where loyal shareholders helped this tiny "metal barn" company get to the NYSE, something which big institution funds are not so easily able to do in the US, due to regulations within the US Stock Market.
Just before the FDA denial letter is released to the company or the public, and before institutions own more than .04 percent of this tiny stock, a pseudonym authored, hedge fund shorting of the stock is unfolding, taking the stock down 60 percent.

Meanwhile, Moffitt Cancer Center has recently released that this novel drug, PV10, is unprecedented, as they reveal that "biopsies of patient tumors collected just 7-14 days after PV-10 injection no longer contained viable tumor tissue" as PV10 also induces immunity, disappears lung tumors after only melanoma leg tumors are injected, eliminates the need to destroy healthy tissues like the popular chemotherapy treatments do, and is eventually able to leave holes in a liver where the tumor had been.

If that isn't enough, PV10 is now being discovered to work successfully on "refractory" lesions which were unsuccessfully treated by all other existing melanoma drugs in the United States of America.

All trading of the company stock is haulted an entire day after the FDA denial letter, just in time for a three day Memorial Day Weekend.

Doctors from cancer centers using PV10 throughout the US have been and still are treating patients with breakthrough results in clinical trials, and are asking Conference Call questions, of why the FDA is not approving a drug, when lives are at stake.

Those in the USA who have been helping this tiny company to its NYSE "nick of time" bell ringing, are gifted with a three day memorializing weekend to sort through this cancer drug hault, spending countless hours, discussing if the FDA decision will allow bankruptcy of this unprecedented cancer drug company, and in the "nick of time" learn Colorado signed into law the so-called “Right to Try” bill on May 17, one day after the FDA May 16 dated denial letter of "breakthrough therapy designation". Nick Auden of Colorado died in November at age 41 of melanoma, after unsuccessfully lobbying two drug companies to use an experimental treatment outside of clinical trials. Auden had acknowledged there was no guarantee the drug would work.

“When you’re terminal and there’s a drug out there that might help you, it can seem that the obstacles to get that drug are insurmountable,” Colorado State Senator Irene Aguilar, a physician and bill co-sponsor, said. Aguilar had taken to calling the legislation the “Dallas Buyers Club” bill, taken from the 2013 film that adapted the story of an AIDS patient who smuggled unapproved pharmaceuticals from Mexico to Texas in order to treat symptoms.

Doctors, Established Cancer Treatment Centers, Company Executives, Inventors, Philanthropic Minded Investors, NYSE, Big Pharmaceutical Companies, FDA, Hedge Funds, Financial Institutions who do not yet own this tiny metal barn stock----and cancer patients----are pondering this quiet breakthrough company

Will doctors, a tiny company with a breakthrough cancer drug and a new Colorado Right To Try Law, collaborate to save lives, while the FDA Officers spend Memorial Day eating carcinogenic grilled steaks? Memorial Day 2014 came and went. Lives are the only thing at "steak".

Will the FDA find yet another way to break this cancer treatment by not complying with the new Congress implemented Breakthrough Therapy Designation Law? No.
What countries will force the United States of America into uniting for cancer?

In this Advance of a New Front in the War against Cancer, what will YOU contribute to this breakthrough for the United States of America?

Colorado Gov. John Hickenlooper speaks at a news conference at the Capitol in Denver in this Wednesday, May 22, 2013 file photo. Hickenlooper Saturday afternoon May 17, 2014 signed Colorado's "Right to Try" bill, which was passed unanimously in the state Legislature. The "Right to Try" law allows terminally ill patients to obtain experimental drugs without getting federal approval. The bill doesn't require drug companies to provide any drug outside federal parameters, and there's no indication pharmaceutical companies will do so. (Source: AP Photo/Ed Andrieski, File)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PVCT News